private:genomicvision
|
303176
|
Dec 3rd, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Dec 3rd, 2020 10:28AM
|
Dec 3rd, 2020 10:28AM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Dec 2nd, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Dec 2nd, 2020 12:51PM
|
Dec 2nd, 2020 12:51PM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Dec 1st, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Dec 1st, 2020 12:32PM
|
Dec 1st, 2020 12:32PM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Nov 30th, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Nov 30th, 2020 01:23PM
|
Nov 30th, 2020 01:23PM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Nov 29th, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Nov 29th, 2020 06:39PM
|
Nov 29th, 2020 06:39PM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Nov 28th, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Nov 28th, 2020 02:14PM
|
Nov 28th, 2020 02:14PM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Nov 27th, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Nov 27th, 2020 10:35AM
|
Nov 27th, 2020 10:35AM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Nov 26th, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Nov 26th, 2020 11:37AM
|
Nov 26th, 2020 11:37AM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Nov 25th, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Nov 25th, 2020 02:45PM
|
Nov 25th, 2020 02:45PM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|
private:genomicvision
|
303176
|
Nov 24th, 2020 12:00AM
|
Genomic Vision
|
2.1K
|
38.00
|
Open
|
Biotechnology
|
Nov 24th, 2020 11:56AM
|
Nov 24th, 2020 11:56AM
|
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These diagnostic tests and drug discovery tools operate where genome dynamics and human disease intersect. GENOMIC VISION uses a powerful technique, Molecular Combing Technology, for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology.
GENOMIC VISION initial focus is towards early cancer detection and drug therapy monitoring. The company possesses an unrivalled capability for discovering genomic biomarkers implicated in the predisposition and development of many forms of cancer and in following and analyzing DNA replication during cell division. This provides a unique approach for evaluating the efficacy of new drugs on the cell cycle.
|
Open
|
Molecular Diagnostics, Cytogenetics, Genomics, DNA replication, DNA repair, Genome maintenance, Structural variation, FSHD, Single DNA molecule
|
Open
|
80 Rue des Meuniers
|
Bagneux
|
Paris Area
|
FR
|
92220
|
|
Genomic Vision
|
|
Pharmaceuticals & Biotechnology
|